CKD Self-Management Mobile Application: A mobile application used by participants to log home blood pressure (twice daily), blood glucose (twice daily, if applicable), medication adherence, and meal photographs (5 days prior to visits). The application also integrates with the hospital information system (HIS) to provide lab test results for disease monitoring.
Study summary
This study evaluates disease progression and management characteristics in patients with chronic kidney disease (CKD) using an integrated mobile application and hospital information system (HIS) clinical data.
The main goals of this study are:
1. To observe patient self-management recording performance and adherence (continuity of recording blood pressure, blood glucose, medication, and diet).
2. To explore associations between integrated self-management data and disease progression or acute exacerbations (e.g., acute kidney injury, hyperkalemia).
3. To gather foundational evidence for optimizing and improving future digital health applications for CKD management.
Participants will be recruited from outpatient clinics at Chungnam National University Hospital and followed prospectively for 1 year with regular follow-up visits.
Eligibility
Sex
ALL
Min age
19 Years
Max age
84 Years
Healthy volunteers
No
Inclusion Criteria:
1. Adult patients aged 19 years or older and under 85 years.
2. Patients visiting the hospital for chronic kidney disease (CKD) management.
3. Patients diagnosed with CKD or identified as high-risk for CKD requiring continuous management (e.g., diabetes mellitus, hypertension, proteinuria, or decreased eGFR).
4. Patients capable of recording self-management data (blood pressure, diet, medication) independently or with assistance through the provided mobile application.
5. Patients whose clinical data can be collected from the Hospital Information System (HIS).
Exclusion Criteria:
1. Patients who do not sign the informed consent form or lack the capacity to fully understand the study protocol and express voluntary consent.
2. Patients currently undergoing maintenance dialysis (hemodialysis or peritoneal dialysis) for end-stage kidney disease (ESKD).
3. Patients deemed unsuitable for participation in the study by the investigator.
Primary outcome measure(s)
Self-Management Data Recording Adherence and Quality — Up to 12 months (evaluated at Visit 1 through Visit 7 at 2-month intervals) Continuity and completion rate of patient-entered self-management logs, including home blood pressure (twice daily), blood glucose (twice daily, if applicable), medication adherence, and meal photographs.
Trial sites (1)
Facility
City
Region
Status
Chungnam National University Hospital
Daejeon
DJ
Recruiting
More Chungnam National University Hospital trials in South Korea
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
